Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Grupo Espanol de Tumores Neuroendocrinos
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
Hospices Civils de Lyon
University of Nebraska
M.D. Anderson Cancer Center
University Health Network, Toronto
University Health Network, Toronto
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fujian Medical University
University Medical Center Groningen
Stanford University
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Nanjing First Hospital, Nanjing Medical University
M.D. Anderson Cancer Center
The First Affiliated Hospital of Xiamen University
West China Hospital
Children's Hospitals and Clinics of Minnesota
Shanghai 6th People's Hospital
Massachusetts General Hospital
Academic and Community Cancer Research United
National Taiwan University Hospital
University College, London
Radboud University Medical Center
National Taiwan University Hospital
UNICANCER
Dana-Farber Cancer Institute
Peking Union Medical College Hospital
Instituto do Cancer do Estado de São Paulo
University of Roma La Sapienza
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Institut Bergonié
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
National Taiwan University Hospital
Chang Gung Memorial Hospital
Medstar Health Research Institute
CHU de Reims
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kentucky
Massachusetts General Hospital